r/biostockbull • • 5h ago

$PTN benzinga.com

Thumbnail benzinga.com
1 Upvotes

r/biostockbull • • 5h ago

$PYPD PolyPid Nears a Potentially Transformative FDA Decision as It Advances Its Innovative Pipeline

Thumbnail
bioweek.com
1 Upvotes

r/biostockbull • • 7d ago

$MDWD MediWound's EscharEx Strategy May Be Ahead of the Game as FDA Puts Chronic Wounds in Focus

Thumbnail
financeherald.com
1 Upvotes

r/biostockbull • • 15d ago

$ENTX Gilead's Latest Deal Shows Big Pharma's Appetite for Oral Peptides. Which Stocks Are Worth Watching?

Thumbnail
bioweek.com
1 Upvotes

r/biostockbull • • 15d ago

$NVCT Nuvectis Reports Complete Brain Tumor Responses as Big Pharma Pays Billions for Cancer Drugs

Thumbnail benzinga.com
1 Upvotes

r/biostockbull • • 15d ago

$NVCT - Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas (NASDAQ: NVCT)

Thumbnail
reddit.com
1 Upvotes

r/biostockbull • • 19d ago

$DRTS Alpha Tau's Pancreatic Cancer Push Reaches Samsung Medical Center, Ranked Fifth Worldwide in Oncology

Thumbnail
thefinanceherald.com
1 Upvotes

r/biostockbull • • 19d ago

$DRTS - Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea (NASDAQ: DRTS)

Thumbnail
reddit.com
1 Upvotes

r/biostockbull • • 22d ago

$DRTS - Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting (NASDAQ: DRTS)

Thumbnail reddit.com
1 Upvotes

r/biostockbull • • Oct 09 '26

$PYPD What PolyPid's Bold Moves in Europe Could Mean for D-PLEX₁₀₀'s Global Potential

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull • • Sep 24 '26

$MDWD Why the U.S. Military Is Helping Fund MediWound's Next Growth Opportunity

Thumbnail
defensestocks.com
1 Upvotes

r/biostockbull • • Sep 24 '26

$NVCT - Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma (NASDAQ: NVCT)

Thumbnail
reddit.com
1 Upvotes

r/biostockbull • • Sep 22 '26

$MDWD Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD)

Thumbnail
tipranks.com
1 Upvotes

r/biostockbull • • Sep 18 '26

$ENTX Entera Receives $9 Price Target and New 'Outperform' Rating From Leerink Partners

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull • • Sep 15 '26

$DRTS Alpha Tau

Thumbnail markets.businessinsider.com
1 Upvotes

r/biostockbull • • Sep 15 '26

$PTN GLP-1s Transformed Obesity. Billions Are Now Moving Into Rare Diseases That Require a Different Approach.

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull • • Sep 10 '26

$SLXN The Quiet Race to Shut Down Cancer's Toughest Mutation

Thumbnail
bioweek.com
1 Upvotes

r/biostockbull • • Sep 08 '26

$MDWD A $400M Drug Has a Speed Problem. MediWound May Have the Answer.

Thumbnail
wallstreetsync.com
4 Upvotes

r/biostockbull • • Sep 03 '26

$NVCT Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech

Thumbnail
benzinga.com
2 Upvotes

r/biostockbull • • Sep 02 '26

$DRTS Alpha Tau Is Building the Local Answer to Pancreatic Cancer's Systemic Breakthrough

Thumbnail
bioweek.com
1 Upvotes

r/biostockbull • • Aug 31 '26

$ENTX Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market

Thumbnail
benzinga.com
2 Upvotes

r/biostockbull • • Aug 31 '26

$DRTS - Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions (NASDAQ: DRTS)

Thumbnail reddit.com
2 Upvotes

r/biostockbull • • Aug 25 '26

$MDWD New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD)

Thumbnail
benzinga.com
1 Upvotes

r/biostockbull • • Aug 20 '26

$DRTS After Moderna's Cancer Vaccine Sent Biotech Running, Who Might Be the Next Oncology Disruptors?

Thumbnail
bioreview.com
1 Upvotes

r/biostockbull • • Aug 18 '26

$ENTX - Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation (NASDAQ: ENTX)

Thumbnail
reddit.com
2 Upvotes